# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-22-020081
Filing Date
2022-05-13
Accepted
2022-05-13 14:17:37
Documents
49
Period of Report
2022-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-8k_20220513.htm iXBRL | 8-K | 36655
2 | EX-99.1 | eypt-ex991_95.htm | EX-99.1 | 29890
3 | GRAPHIC | slide-eoxsbenio2x.jpg | GRAPHIC | 274615
4 | GRAPHIC | slide-dya22dve0xe.jpg | GRAPHIC | 231999
5 | GRAPHIC | slide-w0n1xl1dgwc.jpg | GRAPHIC | 281470
6 | GRAPHIC | slide-oaoop3nprsx.jpg | GRAPHIC | 327583
7 | GRAPHIC | slide-5rhwf1dzrbm.jpg | GRAPHIC | 469771
8 | GRAPHIC | slide-0jxmcs1m4as.jpg | GRAPHIC | 367670
9 | GRAPHIC | slide-yfucjlvdods.jpg | GRAPHIC | 270505
10 | GRAPHIC | slide-rxmr0pwqn2v.jpg | GRAPHIC | 304229
11 | GRAPHIC | slide-xden0yeetp1.jpg | GRAPHIC | 230944
12 | GRAPHIC | slide-taqctr2yorl.jpg | GRAPHIC | 382344
13 | GRAPHIC | slide-kaozcuxplrh.jpg | GRAPHIC | 551002
14 | GRAPHIC | slide-gaqmthhpyqe.jpg | GRAPHIC | 438823
15 | GRAPHIC | slide-zpeue4lucje.jpg | GRAPHIC | 321994
16 | GRAPHIC | slide-usxl31gwju4.jpg | GRAPHIC | 238595
17 | GRAPHIC | slide-ib0ouyfbjoi.jpg | GRAPHIC | 261231
18 | GRAPHIC | slide-n5e0uzpzitr.jpg | GRAPHIC | 308168
19 | GRAPHIC | slide-lpwao0p5jd0.jpg | GRAPHIC | 413712
20 | GRAPHIC | slide-34yu4ntqtxg.jpg | GRAPHIC | 308373
21 | GRAPHIC | slide-2w4e2wxbgbe.jpg | GRAPHIC | 302881
22 | GRAPHIC | slide-xnnyukhiy3v.jpg | GRAPHIC | 435735
23 | GRAPHIC | slide-dnfgt4lei2j.jpg | GRAPHIC | 412332
24 | GRAPHIC | slide-mvosdy0tqjx.jpg | GRAPHIC | 307099
25 | GRAPHIC | slide-zd5fil3fomx.jpg | GRAPHIC | 539825
26 | GRAPHIC | slide-cmle2moe4ae.jpg | GRAPHIC | 408910
27 | GRAPHIC | slide-okyggv1ivks.jpg | GRAPHIC | 335373
28 | GRAPHIC | slide-mveyhqgfc2o.jpg | GRAPHIC | 348180
29 | GRAPHIC | slide-kab0gpp2had.jpg | GRAPHIC | 264599
30 | GRAPHIC | slide-l4kvi2nnios.jpg | GRAPHIC | 310443
31 | GRAPHIC | slide-lusuycr3ctd.jpg | GRAPHIC | 542638
32 | GRAPHIC | slide-zganfln501m.jpg | GRAPHIC | 322362
33 | GRAPHIC | slide-l02lcfsdcia.jpg | GRAPHIC | 255548
34 | GRAPHIC | slide-qgbc23ovyno.jpg | GRAPHIC | 385959
35 | GRAPHIC | slide-mtrzxhchtwl.jpg | GRAPHIC | 235969
36 | GRAPHIC | slide-ckvjdcmujht.jpg | GRAPHIC | 324929
37 | GRAPHIC | slide-wmvhey1bsda.jpg | GRAPHIC | 433023
38 | GRAPHIC | slide-2a4ttkqejfv.jpg | GRAPHIC | 234182
| Complete submission text file | 0001564590-22-020081.txt |  | 17261851

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
39 | XBRL TAXONOMY EXTENSION SCHEMA | eypt-20220513.xsd | EX-101.SCH | 5597
40 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | eypt-20220513_lab.xml | EX-101.LAB | 18574
41 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | eypt-20220513_pre.xml | EX-101.PRE | 11041
43 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-8k_20220513_htm.xml | XML | 3415

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 22921868
SIC: 3826 Laboratory Analytical Instruments